Glutamic Acid Decarboxylase Antibodies and Diabetes Complications: Assay reliability and validity

Lernmark, Åke

doi:10.2337/diacare.18.2.269

Article navigation

Commentary| February 01 1995

Glutamic Acid Decarboxylase Antibodies and Diabetes Complications: Assay reliability and validity

Åke Lernmark, MD

R.H. Williams Laboratory, Department of Medicine, University of Washington

Seattle, Washington

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence and reprint requests to Åke Lemmark, MD, University of Washington, R.H. Williams Laboratory, Department of Medicine, RG-20, Seattle, WA 98195.

Diabetes Care 1995;18(2):269–271

https://doi.org/10.2337/diacare.18.2.269

PubMed:

7729309

Glutamic Acid Decarboxylase Antibodies and Diabetes Complications: Assay reliability and validity

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Glutamic Acid Decarboxylase Antibodies and Diabetes Complications: Assay reliability and validity

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only